Conditions: Metastatic Colorectal Cancer; Metastatic Gastric Cancer; Metastatic Pancreatic Cancer; Metastatic Hepatocellular Carcinoma; Metastatic Cholangiocarcinoma
Interventions: Drug: CD8+ young TIL; Drug: Aldesleukin; Drug: Cyclophosphamide; Drug: Fludarabine
Sponsor: National Cancer Institute (NCI)
Recruiting - verified June 2010
Feeds
4318 items (4318 unread) in 87 feeds
Acinar Cell Carcinoma
(24 unread)
Acinic Cell Carcinoma
(33 unread)
Adenoid Cystic Carcinoma
(83 unread)
Adrenal Gland Cancer
(305 unread)
Ampulla Of Vater
(23 unread)
Anal Cancer
(212 unread)
Angiosarcoma
(79 unread)
Appendix Cancer
(66 unread)
Bile Duct Cancer
(332 unread)
Brain and CNS
(1194 unread)
Carcinoid
(124 unread)
Endocrine/Neuroendocrine
(500 unread)
Gall Bladder Cancer
(89 unread)
General
(4 unread)
Hemangioendothelioma
(38 unread)
HemeOnc
(78 unread)
Hepatoblastoma
(46 unread)
Pancreas
(76 unread)
Phyllodes
(21 unread)
PMP and Mucinous Tumors
(35 unread)
Rhabdomyosarcoma
(175 unread)
Sarcoma
(313 unread)
Twitter Pals
(468 unread)
Trial - Cholangiocarcinoma (23 unread)
-
A Phase II Study Using Short-Term Cultured, CD8+-Enriched Autologous Tumor-infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Difestive Tract Cancers
Posted: July 31st, 2010, 9:00am CDT
-
PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Posted: June 15th, 2010, 9:00am CDT
Conditions: Cholangiocarcinoma; Hepatobiliary Cancers; Hepatobiliary Cancers Liver; Hepatobiliary Cancers Bile Duct; Bile Duct Cancer (Cholangiocarcinoma); Hepatobiliary Cancers Gallbladder; Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma)
Interventions: Procedure: Stereotactic Body Radiotherapy; External photon radiation; Procedure: Systemic chemotherapy; Intravenous route; Procedure: Liver transplant
Sponsor: Stanford University
Recruiting - verified July 2010 -
Comparison of Biliary Forceps Biopsy and Brush Cytology
Posted: June 14th, 2010, 9:00am CDT
Condition: Cholangiocarcinoma
Interventions: Device: double-balloon enteroscopy forceps biopsy; Device: Transpapillary brush cytology
Sponsors: University of Ulm; Department of Internal Medicine, Division of Gastroenterology, University Medical Center Heidelberg, Heidelberg, Germany
Completed - verified May 2010 -
Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct
Posted: April 1st, 2010, 9:00am CDT
Condition: Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct
Intervention: Drug: Glivec
Sponsor: University Hospital Dresden
Completed - verified April 2010 -
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Posted: March 24th, 2010, 9:00am CDT
Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: sorafenib tosylate
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma
Posted: September 10th, 2009, 9:00am CDT
Condition: Cholangiocarcinoma
Intervention: Drug: WST11
Sponsor: Steba Biotech S.A.
Recruiting - verified May 2010 -
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Posted: August 18th, 2009, 9:00am CDT
Conditions: Anal, Colon, and Rectal Cancers; Blood Cancer; Breast Cancer; Prostatic Neoplasms; Colorectal Neoplasms; Amyloidosis; Anal Cancer; Anemia; Bile Duct Cancer (Cholangiocarcinoma); Bladder (Urothelial, Transitional Cell) Cancer; Blood and Marrow Transplant (BMT); Bone Cancer; Brain (Nervous System) Cancers; Colon/Rectal Cancer; Endocrine Cancer; Esophageal Cancer; Eye Cancer; Gall Bladder Cancer; Gastric (Stomach) Cancer; Gastro-Esophageal(GE) Junction Cancer; Gastrointestinal Stromal Tumor (GIST); Gynecologic Cancers; Head and Neck Cancers; Hepatobiliary Cancers; Kidney (Renal Cell) Cancer; Leukemia; Lung Cancer; Lymphoma: Hodgkin; Lymphomas: Non-Hodgkin; Mesothelioma; Multiple Myeloma; Myelodysplastic Syndromes (MDS); Myeloproliferative Disorders (MPD); Neuroendocrine Tumors; Pancreatic Cancer; Prostate Cancer; Soft Tissue Sarcoma; Testicular Cancer; Thymus Cancer; Thyroid Cancer
Intervention: Behavioral: Cancer: Thriving and Surviving Online Workshop
Sponsors: Stanford University; University of Hawaii Cancer Research Center; McMillian Trust
Recruiting - verified July 2010 -
Imaging and Biomarkers of Hypoxia in Solid Tumors
Posted: July 27th, 2009, 9:00am CDT
Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma); Anoxia; Lung Cancer; Lung Cancer Non-Small Cell Cancer (NSCLC); Pancreatic Cancer; Head and Neck Cancers; Anal Cancer; Bile Duct Cancer (Cholangiocarcinoma); Bladder (Urothelial, Transitional Cell) Cancer; Bone Cancer; Brain (Nervous System) Cancers; Breast Cancer; Colon/Rectal Cancer; Endocrine Cancer; Esophageal Cancer; Eye Cancer; Gastric (Stomach) Cancer; Gall Bladder Cancer; Gastro-Esophageal(GE) Junction Cancer; Gastrointestinal Stromal Tumor (GIST); Gynecologic Cancers; Hepatobiliary Cancers; Kidney (Renal Cell) Cancer; Lymphoma: Hodgkin; Lymphomas: Non-Hodgkin; Neuroendocrine Tumors; Prostate Cancer; Skin Cancer; Soft Tissue Sarcoma; Testicular Cancer; Thymus Cancer; Thyroid Cancer
Interventions: Procedure: PET Scan; Procedure: Biomarker Analysis
Sponsor: Stanford University
Not yet recruiting - verified June 2010 -
Confocal Endomicroscopy for Biliary Strictures -Phase I
Posted: May 1st, 2009, 9:00am CDT
Condition: Biliary Stricture
Intervention: Procedure: ERCP and Confocal imaging
Sponsors: Mayo Clinic; Sigma Tau Pharmaceuticals, Inc.
Recruiting - verified July 2010 -
Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Posted: November 12th, 2008, 9:00am CST
Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer
Interventions: Drug: capecitabine; Drug: gemcitabine hydrochloride; Procedure: adjuvant therapy; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
Posted: September 15th, 2008, 9:00am CDT
Conditions: Biliary Tract Cancer; Gallbladder Cancer; Cancer Of The Extrahepatic Bile Duct; Ampullary Carcinoma
Interventions: Drug: ZD6474, VANDETANIB; Drug: ZD6474, VANDETANIB; Drug: GEMCITABINE; Drug: Placebo matching ZD6474
Sponsor: AstraZeneca
Recruiting - verified July 2010 -
Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)
Posted: August 18th, 2008, 9:00am CDT
Condition: Depression
Intervention: Behavioral: Lifestyle Counseling with Emotional Freedom Techniques (EFT)
Sponsor: Soul Medicine Institute
Recruiting - verified May 2010 -
Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma
Posted: July 21st, 2008, 9:00am CDT
Condition: Cholangiocarcinoma
Interventions: Device: biliary stent (self expandable metallic stent); Device: biliary stent ( Amsterdam type plastic stent)
Sponsor: Khon Kaen University
Active, not recruiting - verified June 2010 -
Liver Transplantation for Cholangiocarcinoma: An Effective Therapy
Posted: June 27th, 2008, 9:00am CDT
Conditions: Cancer; Cholangiocarcinoma; Liver
Intervention: Procedure: Liver Transplantation
Sponsor: University of Utah
Active, not recruiting - verified June 2010 -
Identification of Key Blood Molecular Markers for Immunotherapy
Posted: July 24th, 2007, 9:00am CDT
Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma); Anal Cancer; Bile Duct Cancer (Cholangiocarcinoma); Bladder (Urothelial, Transitional Cell) Cancer; Blood and Marrow Transplant (BMT); Bone Cancer; Brain (Nervous System) Cancers; Breast Cancer; Colon/Rectal Cancer; Endocrine Cancer; Esophageal Cancer; Eye Cancer; Gall Bladder Cancer; Gastric (Stomach) Cancer; Gastro-Esophageal(GE) Junction Cancer; Gastrointestinal Stromal Tumor (GIST); Gynecologic Cancers; Head and Neck Cancers; Hepatobiliary Cancers; Kidney (Renal Cell) Cancer; Leukemia; Lung Cancer; Lymphoma: Hodgkin; Lymphomas: Non-Hodgkin; Mesothelioma; Multiple Myeloma; Myelodysplastic Syndromes (MDS); Myeloproliferative Disorders (MPD); Neuroendocrine Tumors; Pancreatic Cancer; Prostate Cancer; Skin Cancer; Soft Tissue Sarcoma; Testicular Cancer; Thymus Cancer; Thyroid Cancer
Intervention: Procedure: phlebotomy
Sponsor: Stanford University
Recruiting - verified August 2010 -
Storage of Bile From Routine Procedures to Study Risk Factors
Posted: December 21st, 2006, 9:00am CST
Conditions: Gallbladder Cancer; Cholangiocarcinoma; Biliary Tract Cancer
Intervention:
Sponsor: Indiana University School of Medicine
Recruiting - verified June 2010 -
Bevacizumab and Erlotinib in Treating Patients With Metastatic or Unresectable Biliary Tumors
Posted: July 26th, 2006, 9:00am CDT
Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer
Interventions: Biological: bevacizumab; Drug: erlotinib hydrochloride; Genetic: molecular diagnostic method; Genetic: mutation analysis; Genetic: protein expression analysis; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Active, not recruiting - verified January 2009 -
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Posted: July 5th, 2006, 9:00am CDT
Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma); Anal Cancer; Bile Duct Cancer (Cholangiocarcinoma); Bladder (Urothelial, Transitional Cell) Cancer; Blood and Marrow Transplant (BMT); Bone Cancer; Brain (Nervous System) Cancers; Breast Cancer; Colon/Rectal Cancer; Endocrine Cancer; Esophageal Cancer; Eye Cancer; Gall Bladder Cancer; Gastric (Stomach) Cancer; Gastro-Esophageal(GE) Junction Cancer; Gastrointestinal Stromal Tumor (GIST); Gynecologic Cancers; Head and Neck Cancers; Hepatobiliary Cancers; Kidney (Renal Cell) Cancer; Leukemia; Lung Cancer; Lymphoma: Hodgkin; Lymphomas: Non-Hodgkin; Mesothelioma; Multiple Myeloma; Myeloproliferative Disorders (MPD); Myelodysplastic Syndromes (MDS); Neuroendocrine Tumors; Pancreatic Cancer; Prostate Cancer; Skin Cancer; Soft Tissue Sarcoma; Testicular Cancer; Thymus Cancer; Thyroid Cancer
Intervention: Procedure: blood draw
Sponsor: Stanford University
Recruiting - verified August 2010 -
Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Posted: March 8th, 2006, 9:00am CST
Condition: Cholangiocarcinoma
Intervention: Other: Observation data collection study.
Sponsor: Washington University School of Medicine
Recruiting - verified June 2010 -
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
Posted: April 9th, 2002, 9:00am CDT
Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
Intervention: Drug: erlotinib hydrochloride
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Completed - verified July 2010 -
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
Posted: December 7th, 2001, 9:00am CST
Conditions: Breast Cancer; Colorectal Cancer; Gallbladder Cancer; Gastric Cancer; Head and Neck Cancer; Liver Cancer; Ovarian Cancer; Pancreatic Cancer; Testicular Germ Cell Tumor
Interventions: Biological: CMV pp65 peptide; Biological: autologous dendritic cells/CMV pp65 peptide mixture; Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine; Biological: tetanus toxoid; Biological: therapeutic autologous dendritic cells
Sponsors: Duke University; National Cancer Institute (NCI)
Completed - verified September 2005 -
SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
Posted: July 11th, 2001, 9:00am CDT
Condition: Liver Cancer
Interventions: Drug: gemcitabine hydrochloride; Drug: lonafarnib; Procedure: conventional surgery
Sponsors: University of California, Los Angeles; National Cancer Institute (NCI)
Completed - verified July 2010 -
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
Posted: July 5th, 2000, 9:00am CDT
Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
Intervention: Drug: becatecarin
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Terminated - verified June 2010